Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
ULIS-1 is an open-label pilot study concerning utility of molar sodium lactate in fluid balance in septic shock patients
Full description
ULIS-1 consists in three arms of treatment during the first 24hrs of septic shock treatment.
normal saline sodium lactate 2.5ml/kg in 60min then either 0.25 or 0.5ml/kg/h during 24hrs Main criteria is fluid balance at 48hrs
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
90 participants in 3 patient groups
Loading...
Central trial contact
Raphaël Favory, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal